InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Boulding Mark Elliott. Officer active across 1 company, notably PTC Therapeutics, INC.. Aggregated, 2 filings have been logged. Activity tracked since 17 June 2026. The latest transaction was filed on 6 July 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations